Acute ischemic stroke (AIS) is the leading cause of adult disability in the United States and a major cause of death both ...

Intravenous thrombolysis with recombinant tissue plasminogen activator is considered the standard of care in patients with acute ischemic stroke presenting within 4.5 h after onset. Neuroimaging ...

DiaMedica Therapeutics progresses DM199 for ischemic stroke and preeclampsia, aiming to expand treatment windows. Read why ...

Endovascular thrombectomy is highly effective for acute ischemic stroke due to large-vessel occlusion, but its efficacy and safety for stroke due to medium-vessel occlusion remain unclear.

In March, the FDA approved one-time, 5-second IV bolus tenecteplase (TNKase, Genentech) for the treatment of acute ischemic stroke in adults. As Healio previously reported, tenecteplase is the ...

Imperative Care announced that it intends to fund a trial comparing its Zoom stroke system plus best medical treatment to ...

Background: Dual antiplatelet therapy is the standard of care for acute coronary syndrome ... nonfatal myocardial infarction, or ischemic stroke. The primary safety end point was hospital admissions ...

An autologous point-of-care cell therapy for adults with ischemic HF with reduced ejection fraction was safe and may be beneficial for select candidates, though a pivotal study did not meet its ...

Angioplasty is now frequently utilized for revascularization in acute stroke patients and is ... have been used in the setting of treatment of acute ischemic strokes. [66] Numerous case series ...